Research Site — Ottawa, Ontario

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

504

Registered studies

136

Active

Recruiting now

289

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · HR Low-Positive/HER2-Negative Breast Neoplasms · Advanced Non-Small Cell Lung Cancer · HER2- Negative Breast Cancer

Recently updated registry entries

NCT07222332 — A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults… (Recruiting)
NCT06793215 — A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus… (Recruiting)
NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.